Understand Your Health with the Cancer Screening and Monitoring Panel

Cancer Screening and Monitoring Panel
  • Shield IconScreen for 10 common types of cancer in Vietnam
  • Shield IconBreast, lung, gastric, hepatobiliary, colorectal, head and neck, endometrial, ovarian, pancreatic, esophageal cancers
  • Shield IconSupport comprehensive monitoring and clinical assessment with physicians
Cancer Screening and Monitoring Panel

  • Adults, particularly individuals aged 40 years and older

  • Younger individuals with a family history of cancer

  • Individuals who smoke or are regularly exposed to secondhand smoke

  • Individuals with heavy alcohol consumption or substance use

  • Individuals who live or work in environments with significant exposure to chemicals or radiation

  • Individuals with abnormal findings on laboratory tests, ultrasonography, endoscopy, X-ray, CT, or MRI who have been advised by a physician to undergo further evaluation

  • Individuals with a history of polyps, precancerous lesions, dysplasia, or other abnormalities associated with an increased risk of progression to cancer

  • Individuals diagnosed with cancer who are currently undergoing treatment

  • Individuals with concerning signs or symptoms, such as an unexplained mass or enlarged lymph nodes, persistent cough, coughing up blood (hemoptysis), or persistent changes in urinary habits

The panels are designed to support the comprehensive assessment of biomarkers associated with several types of cancer commonly found in Vietnam.

By analyzing blood-based biomarkers in combination with molecular biology techniques, these tests provide additional information to assist physicians in patient monitoring, risk assessment, and the identification of abnormalities that may warrant further diagnostic evaluation.


   Early Cancer & Chronic Disease Screening: An integrated solution combining early screening for 10 common types of cancer with risk assessment for four chronic conditions commonly affecting the Vietnamese population: diabetes mellitus, dyslipidemia, liver disease, and kidney disease.

   Tumor Marker - Men: Focuses on the assessment of biomarkers associated with several cancers commonly affecting men, with particular emphasis on prostate cancer.

   Tumor Marker - Women: Focuses on the assessment of biomarkers and related factors associated with several cancers commonly affecting women, including breast, cervical, and ovarian cancers.


Important Note: Screening results and biomarker levels should be interpreted by a physician in conjunction with the patient’s medical history and clinical examination. If abnormalities are identified, appropriate diagnostic investigations may be required to establish or confirm a diagnosis.

Đăng ký tư vấn nhanh!

Cancer Screening and Monitoring Panel

Turnaround Time

After 2 hour and 20 minutes on the same day
If the Lab receives the sample before 9:30 PM (Monday to Saturday) or before 8:30 PM (Sunday)
By 8:50 AM the following day
If the Lab receives the sample after 9:30 PM (Monday to Saturday) or after 8:30 PM (Sunday)
By 4:50 PM on the same day (Tumor Marker - Women)
If the Lab receives the sample before 10:00 AM
By 10:00 AM 16 days later (Early Cancer & Chronic Disease Screening)
If the Lab receives the sample before 2:00 PM, Monday to Friday

Pre-Test Instructions

  • Fasting is not required
  • Fast for 8 - 12 hours before sample collection if you are undergoing the Early Cancer & Chronic Disease Screening Panel
  • Avoid alcoholic beverages for 24 hours before sample collection, drink only plain water
  • Inform DIAG of all medications and dietary supplements you are currently taking
  • Contact DIAG directly for specific sample collection instructions appropriate to your individual circumstances

Seasonal promotions

15%

15% OFF - National Health Screening Program

HOT SALE See promo
4,349,000 VND

Only 4,349,000 VND - Early Cancer & Chronic Disease Screening Panel

HOT SALE See promo
100% Sure Win

Lucky Wheel - 100% Guaranteed Gifts for the Soft Opening of New PSC

HOT SALE See promo
150,000 VND

Receive Vouchers of Up to 150,000 VND when referring friends via DIAG App

HOT SALE See promo
Home Sample Collection
FREE

Any time, any test

Book Now Home sample collection
Extensive Network Across Southern Vietnam
40+ PSCs

Ho Chi Minh City, Binh Duong, Vung Tau, Long An, Tien Giang, and more

View Locations locations

Why Choose DIAG?

Reliable Test Results at DIAG for Accurate Medical Diagnosis and Treatment

3,500,000+

Annual Test Volume

2,400+

Trusted Doctor Partners

350+

Affiliated Hospitals & Clinics

450+

Diverse Tests

Trusted by Leading Healthcare Partners

DIAG Committed to Operating in Accordance with International Standards and Regulations of the Ministry of Health

DIAG Utilizes Advanced Automated Technologies from Europe and the United States to Deliver Accurate and Reliable Test Results

img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery img-gallery

Frequently Asked Questions

An elevated tumor marker level does not necessarily mean that a person has cancer. Rather, it indicates a biological change that may require further evaluation based on the individual’s clinical context.

Some tumor markers may be elevated in the presence of a malignant tumor. However, benign conditions such as inflammation, infection, liver disease, kidney dysfunction, biliary tract disorders, and certain physiological conditions may also cause tumor marker levels to increase.

A cancer diagnosis is not made based on a single tumor marker result. Instead, physicians assess the degree of elevation and changes in marker levels over time, together with the patient’s symptoms and medical history. Additional investigations, such as ultrasonography, CT or MRI, endoscopy, biopsy, or other appropriate diagnostic procedures, may be recommended to determine the underlying cause.

No. Tumor marker levels within the reference range cannot definitively rule out cancer. Each tumor marker has different sensitivity and specificity, and not all tumors produce or release enough of a particular marker into the bloodstream to exceed the established reference range.

Tumor marker levels in some early-stage cancers may remain within the reference range and therefore appear “normal.”

The tested tumor marker should therefore be interpreted as no elevation of the tested tumor marker detected at the time of testing, rather than definitive evidence that cancer is absent. Cancer risk assessment should still consider factors such as age, sex, family history, symptoms, and the results of other appropriate screening or diagnostic investigations.

Not all chronic diseases lead to cancer. However, certain chronic conditions may increase the risk of specific types of cancer, particularly when they cause persistent inflammation, tissue damage, or prolonged cycles of cellular injury and regeneration over many years.

  • Chronic viral hepatitis and cirrhosis are associated with an increased risk of liver cancer.
  • Diabetes mellitus and certain metabolic disorders have also been associated with an increased risk of several types of cancer.

Having these conditions does not mean that a person will develop cancer. An individual’s cancer risk is influenced by multiple factors, including age, genetic factors, family history, smoking, alcohol consumption, diet, physical activity, and environmental exposures.

Importantly, certain chronic diseases may also cause elevated tumor marker levels in the absence of cancer. Therefore, all laboratory results should be interpreted comprehensively in the context of the individual’s clinical condition and relevant risk factors.

Book Test Zalo Button Messenger Button promotion